RecruitingNot ApplicableNCT05704582
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
A Randomized Controlled Trial Comparing Avatar Intervention to an Addiction Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
Sponsor
Ciusss de L'Est de l'Île de Montréal
Enrollment
150 participants
Start Date
Feb 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to conduct a single-blind randomized controlled trial to verify whether the Avatar Intervention has greater efficacy over supportive intervention to reduce cannabis use in patients with psychotic disorders.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Males or females over 18 years of age who meet the DSM-5 criteria for CUD (≥4 criteria) ;
- Patients will meet the DSM-5 criteria for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic symptoms. Diagnoses will be established with the Structured Interview for DSM-5 (SCID-5).
Exclusion Criteria6
- Current SUD for a substance other than cannabis ;
- Ongoing pharmacological or psychological treatment for CUD ;
- Ongoing detoxification for cannabis withdrawal ;
- Presence of neurological disorders ;
- Presence of a severe and unstable physical illness ;
- Inability to provide consent.
Interventions
OTHERAvatar Intervention
8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.
OTHERAddiction supportive intervention
8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05704582
Related Trials
Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders
NCT074559291 location
Racial Disparities in the Expression of Paranoia
NCT074604531 location
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
NCT059202521 location
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
NCT073952061 location
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
NCT068788591 location